<?xml version="1.0" encoding="UTF-8"?>
<ref id="B22-antioxidants-09-01083">
 <label>22.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Arai</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Hashimoto</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Sumitomo</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Takase</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Ishii</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Disease state changes and safety of long-term donepezil hydrochloride administration in patients with Alzheimerâ€™s disease: Japan-Great Outcome of Long-term trial with Donepezil (J-GOLD)</article-title>
  <source>Psychogeriatrics</source>
  <year>2018</year>
  <volume>18</volume>
  <fpage>402</fpage>
  <lpage>411</lpage>
  <pub-id pub-id-type="doi">10.1111/psyg.12340</pub-id>
  <?supplied-pmid 29993162?>
  <pub-id pub-id-type="pmid">29993162</pub-id>
 </element-citation>
</ref>
